Korsana Biosciences, Inc. (KRSA)

NASDAQ: KRSA · Real-Time Price · USD

31.42

-0.58 (-1.81%)

Oct 1, 2026, 3:42 PM EDT - Market open

Korsana Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,431	5	9
Market Cap Growth	18222.49%	-42.87%	-
Last Close Price	32.00	8.89	22.54

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
PB Ratio	11.35	0.04	0.87
P/TBV Ratio	-	-	132.22
P/OCF Ratio	-	-	33.06

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Debt / Equity Ratio	-1.03	-1.09	-1.01
Quick Ratio	17.28	12.34	129.59
Current Ratio	17.40	12.38	129.59
Return on Equity (ROE)	-	-47.02%	-
Return on Assets (ROA)	-	-28.30%	-
Return on Capital Employed (ROCE)	-40.00%	-26.20%	-6.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Oct '26 Oct 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Earnings Yield	-3.36%	-714.97%	-6.05%
Buyback Yield / Dilution	-	-93.49%	-